|
 |
irbesartan hydrochlorothiazideThis page contains recent news articles, when available, and an overview of irbesartan hydrochlorothiazide but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.CHICAGO, IL -- May 23, 2007 -- Treatment with a fixed-dose combination of irbesartan and hydrochlorothiazide (HCTZ) provides equal blood pressure control in ... DG News … use summaries of positive opinion for Irbesartan/Hydrochlorothiazid... - Nov 17, 2006 The benefit with Irbesartan Hydrochlorothiazide BMS is that the combination of the two ingredients has an additive antihypertensive effect, reducing blood ... Pay-Per-View - EMEA (European Medicines Agency) - Factiva, from Dow Jones Effect of irbesartan on erectile function in patients with hypertensio... - Mar 30, 2008 Correspondence: Dr M Baumhäkel, Kardiologie, Angiologie und Internistische Intensivmedizin, Klinik für Innere Medizin III, Universitätsklinikum des ... Nature.com Article: FDA panel backs Avalide as first-line HT therapy.(Cardiovascu... - Jun 1, 2007 Pharma Marketletter; November 26, 2007 ; 680 words ... ... approved the antihypertensive agent Avalide (irbesartan hydrochlorothiazide ... need multiple ... Pay-Per-View - Internal Medicine News - HighBeam Research Initiating Treatment With Combination Angiotensin Receptor Blocker/ … - May 18, 2006 By Ed Susman. NEW YORK, NY -- May 18, 2006 -- Patients with moderate to severe high blood pressure get greater benefit from initial treatment with ... DG News Irbesartan/diuretic Combination Gets 80% of Women to Blood Pressure … - May 23, 2006 ..."Overall, irbesartan/hydrochlorothiazide was associated with a 22.9 mm Hg ... The "Irbesartan/hydrochlorothiazide Blood Pressure Reductions In Diverse ... DG News Patients Who Fail Anti-Hypertensive Monotherapy Respond to Fixed- … - May 19, 2005 After 18 weeks of treatment with the combination of irbesartan/hydrochlorothiazide, 77% of the patients were able to attain their blood pressure goals. ... DG News New Drug Algorithms, New Drug Approvals, New Drugs - Jan 24, 2008 Many questions are potentially answered in the news this month, starting with the STITCH trial from Canada, comparing a stepped care treatment algorithm vs ... Medscape US FDA reviewer supports new use for Bristol drug - Apr 16, 2007 WASHINGTON, April 16 (Reuters) - Bristol-Myers Squibb Co.'s (BMY.N) drug Avalide should be approved for hypertension in patients who are unlikely to lower ... Reuters Press Release: Powerful New Efficacy Data in Moderate and Severe … - Nov 19, 2007 Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R) (Irbesartan-Hydrochlorothiazide) as the First ... Pay-Per-View - PR Newswire - HighBeam Research Hard-to-treat HT responded to simple regimen.(Cardiovascular Medicine) - Jul 15, 2005 SAN FRANCISCO -- A simple, aggressive hypertension treatment regimen controlled systolic hypertension in 77% of 1005 hard-to-treat patients after 18 weeks, ... Free with registration - Internal Medicine News - AccessMyLibrary.com Combo drug controls hypertension in hard-to-treat patients - May 18, 2005 A multi-center study of a pill that combines two drugs for hypertension shows significant benefit for people with hard-to-control high blood pressure. ... Medical News Today - Medical News Today (press release) Abstract and Introduction - Jan 9, 2006 Background: Obesity-associated hypertension is difficult to treat and puts patients at a substantially increased risk of cardiovascular events. ... Medscape Article: Prescribing chlorthalidone not as easy as ABC.(Cardiovascular... - Sep 15, 2007 Prescribing chlorthalidone not as easy as ABC.(Cardiovascular Medicine) ... find Internal Medicine News articles. CHICAGO -- Despite its superior efficacy, ... Pay-Per-View - Internal Medicine News - HighBeam Research Combo drug controls hypertension in hard-to-treat patients - May 23, 2005 Bristol-Myers Squibb/Sanofi-Synthelabo Partnership. They are makers of AVALIDE®, the irbesartan-hydrochlorothiazide combination medicine used in the study. i-newswire.com OnMedica - News: The European Commission has granted an approval … - Sep 6, 2006 We hope you have enjoyed your visit so far. We notice that you're not currently an onmedica.com member. Would you like to join? Tell me more... ... OnMedica Doctors Eager to Use First-Line, Singe-Pill Combo - Aug 11, 2008 By Catherine Hollingsworth. The recent approval of Novartis AG's Diovan/HCT and Exforge as a first-line, single pill combination for high blood pressure ... BioWorld Online - BioWorld Online Hypertension Drug Combination Yields High Rate of Blood Pressure … - Sep 19, 2005 A multi-center study of a pill that combines two drugs for hypertension shows significant benefit for people with hard-to-control high blood pressure. ... emaxhealth.com Hypertension so many treatments, yet so undermanaged: rising in … - Jan 28, 2008 ...for Diovan (valsartan, Novartis) and Avalide (irbesartan-hydrochlorothiazide, Bristol-Myers Squibb), HTN is certainly not devoid of therapeutic options. ... Free with registration - Drug Topics - AccessMyLibrary.com Hard-to-treat HT responded to simple regimen.(Cardiovascular Medicine)... - Jul 15, 2005 Hard-to-treat HT responded to simple regimen.(Cardiovascular Medicine) ... find Internal Medicine News articles. SAN FRANCISCO -- A simple, ... Pay-Per-View - Internal Medicine News - HighBeam Research Avalide.(FDA actions in brief)(Drug overview)(Brief article) - Jan 1, 2008 Irbesartan/hydrochlorothiazide (Avalide, Sanofi-Aventis/ Bristol-Myers Squibb) was approved for initial use in patients with hypertension who are likely to ... Free with registration - Formulary - AccessMyLibrary.com Combo therapy.(RXs)(Bristol-Myers Co. and Sanofi-Aventis SA gets … - Dec 17, 2007 Bristol-Myers and sanofi-aventis have been given approval of Avalide (irbesartan-hydrochlorothiazide), said to be the first combination therapy for initial ... Free with registration - Chain Drug Review - AccessMyLibrary.com Universal Forest Products Inc acquires GeoMatrix Inc - Deal Snapshot ... - Aug 21, 2006 BMY ) Products: Avalide (Irbesartan/Hydrochlorothiazide) Forest Laboratories, Inc. ( FRX ) Products: Benicar HCT (Olmesartan Medoxomil/Hydrochlorothiazide… ... Pay-Per-View - deals - Alacra Store Article: Combo therapy.(RXs)(Bristol-Myers Co. and Sanofi-Aventis SA ... - Dec 17, 2007 Combo therapy.(RXs)(Bristol-Myers Co. and Sanofi-Aventis SA gets approval of avalide)(Brief article) ... find Chain Drug Review articles. Pay-Per-View - Chain Drug Review - HighBeam Research Combo therapy. - Dec 17, 2007 Combo therapy. Bristol-Myers and sanofi-aventis have been given approval of Avalide (irbesartan-hydrochlorothiazide), said to be the first combination ... $9.94 - Chain Drug Review - Alacra Store FDA clears Avalide as initial high BP therapy. - Nov 26, 2007 The US Food and Drug Administration has approved the antihypertensive agent Avalide (irbesartan hydrochlorothiazide) as an initial treatment for ... $4.95 - Pharma Marketletter - ECNext 藥物å??冊知多Ｄ：治療高血壓：æœ?è—¥é?›ç…‰é›™ç®¡é½Šä¸‹- é¦™æ¸¯æ–‡åŒ¯å ± - Jul 27, 2005 ...編者按7月ä¸æ—¬ï¼Œé†«ç®¡å±€æ£å¼?推行藥物å??冊，首先在北å?€é†«é™¢æŽ¨è¡Œï¼Œè€Œæœªä¾†æ•¸æœˆå°‡é€?æ¥åœ¨ 所有è?¯ç¶²çš„醫院和診所實施。實施這一新的制度，標誌著香港醫療體制的一個é‡?大變化， ... 香港文汇报 - 香港文汇报 Компании Mylan Pharmaceuticals разрешен выпуÑ?к дженерика … - Jun 20, 2008 КомпаниÑ? Mylan Pharmaceuticals, подразделение американÑ?кой Mylan, получила разрешение УправлениÑ? по контролю за качеÑ?твом продуктов и медикаментов СШÐ? (FDA) ... ФармацевтичеÑ?кий веÑ?тник Pr Djamila Adghar. Cardiologue au CNMS - Apr 7, 2008 C'est un indice qui permet de faire une évaluation de l'efficacité thérapeutique des antihypertenseurs, sachant que près d'un milliard de personnes ... El Watan Article: Drug Compound Restores Youth to Aging Arterial Cells in... - Nov 15, 2005 Drug Compound Restores Youth to Aging Arterial Cells in Elderly Hypertensives, Hopkins Study Shows; Stiff Arteries Relax Like Younger Blood Vessels After ... Pay-Per-View - AScribe Health News Service - HighBeam Research |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |